The RNF146 expression level showed correlations with several clinical pathological factors, including tumor size, differentiation level, lymphatic metastasis, pTNM staging, and the prognosis of patients in stage I, which are important factors that represent the potential for lung cancer malignancy. This evidence concerns the gene RNF146 and lung carcinoma.